Breaking News, Collaborations & Alliances

Hovione Partners with Zerion Pharma to Market and Commercialize Dispersome

Together, they will bring Zerion´s proprietary solubility enhancement technology platform to the market faster.

Author Image

By: Charlie Sternberg

Associate Editor

Hovione has entered a strategic partnership with Zerion Pharma to market and commercialize Dispersome, Zerion´s proprietary solubility enhancement technology platform.   Zerion´s Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying. By combining Dispersome technology with Hovione’s unique spray drying capabilities, experience in development, scale-up and GM...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters